Experience of the Transplant Team Is an Important Factor for Posttransplant Survival in Patients With Hepatocellular Carcinoma Undergoing Living-Donor Liver Transplantation

Transplantation Proceedings

Volumn 40, Issue 8, 2008, Pages 2507-2509

  Majeed, T A ^a   Wai, C T ^a   Rajekar, H ^a   Lee, K H ^a   Wong, S Y ^a   Leong, S O ^a   Singh, R ^a   Tay, K H ^a   Chen, J ^a   Tan, K C ^a  

^a Asian Center for Liver Diseases and Transplantation   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EVEROLIMUS; NAXAFAR; RAPAMYCIN; SORAFENIB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER SURVIVAL; CAUSE OF DEATH; CHEMOEMBOLIZATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ITALY; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SURVIVAL TIME; TREATMENT OUTCOME; WORK EXPERIENCE;

CARCINOMA, HEPATOCELLULAR; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; PATIENT CARE TEAM; PATIENT SELECTION; POSTOPERATIVE PERIOD; SURVIVORS; TIME FACTORS;

EID: 53149153170     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.010     Document Type: Article

References (9)

1. Tan K.C. Liver transplantation for hepatocellular carcinoma: how far can we push the envelope?. Singapore Med J 44 (2003) 309
2. Mark K.S., and Tan K.C. Liver transplantation for hepatocellular carcinoma: an Asian perspective. Asian J Surg 25 (2002) 271
3. Low H.C., Da Costa M., Prabhakaran K., et al. Impact of new legislation on presumed consent on organ donation on liver transplant in Singapore: a preliminary analysis. Transplantation 82 (2006) 1234
4. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693
5. Wai C.T., Lo S.K., Lee K.H., et al. Liver transplantation in hepatocellular carcinoma. Transplant Proc 32 (2000) 2173
6. Lo C.M., Fan S.T., Liu C.L., et al. Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg 240 (2004) 151
7. Soin A.S., and Vasudevan K.R. A successful deceased-donor liver transplant program is not a prerequisite for a living-donor program. Indian J Gastroenterol 25 (2006) 305
8. Jonas S., Mittler J., Pascher A., et al. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center. Liver Transpl 13 (2007) 896
9. Soejima Y., Taketomi A., Yoshizumi T., et al. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 75 (2003) S37